References
- Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the “common” neurologic disorders? Neurology. 2007;68:326–337.
- Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy A systematic review and meta-analysis of international studies. Neurology. 2017;88:296–303.
- Baftiu A, Feet SA, Larsson PG, et al. Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015. Epilepsy Res. 2018;139:35–42.
- Verrotti A, Tambucci R, Di Francesco L, et al. The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection. Expert Rev Neurother. 2020;20:167–173.
- Verrotti A, Iapadre G, Di Donato G, et al. Pharmacokinetic considerations for anti-epileptic drugs in children. Expert Opin Drug Metab Toxicol. 2019;15:199–211.
- Verrotti A, Trotta D, Salladini C, et al. Risk factors for recurrence of epilepsy and withdrawal of antiepileptic therapy: a practical approach. Ann Med. 2003;35:207–215.
- Berg AT, Shinnar S. Relapse following discontinuation of antiepileptic drugs: a meta-analysis. Neurology. 1994;44:601–608.
- Specchio LM, Beghi E. Should antiepileptic drugs be withdrawn in seizure-free patients? CNS Drugs. 2004;18:201–212.
- Lamberink HJ, Otte WM, Geerts AT, et al. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. Lancet Neurol. 2017;16:523–531.
- Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51:1069–1077.
- Vecchi M, Barba C, De Carlo D, et al. Symptomatic and presumed symptomatic focal epilepsies in childhood: an observational, prospective multicentre study. Epilepsia. 2016;57:1808–1816.
- Glauser T, Ben-Menachem E, Bougeois B, et al. Update ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;54:551–563.
- Parisi P, Matricardi S, Tozzi E, et al. A. Benign epilepsy of childhood with centro-temporal spikes (BECTS) versus migraine: a neuropsychological assessment. Childs Nerv Syst. 2012;28:2129–2135.
- Thiele EA, Granata T, Matricardi S, et al. Transition into adulthood: tuberous sclerosis complex, Sturge-Weber syndrome, and Rasmussen encephalitis. Epilepsia. 2014;55(Suppl 3):29–33.
- Freri E, Matricardi S, Gozzo F, et al. Perisylvian, including insular, childhood epilepsy: presurgical workup and surgical outcome. Epilepsia. 2017;58:1360–1369.
- Olmez A, Arslan U, Turanli G, et al. Risk of recurrence after drug withdrawal in childhood epilepsy. Seizure. 2009;18:251–256.
- Operto FF, Mazza R, Pastorino GMG, et al. Antiepileptic drug withdrawal in children: an update. Curr Pediatr Res. 2019;23:77–81.
- Beghi E, Giussani G, Grosso S, et al., Withdrawal of antiepileptic drugs: guidelines of the Italian league against epilepsy. Epilepsia. 54(Suppl 7): 2–12. 2013.
- Strozzi I, Nolan SJ, Sperling MR, et al. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev. 2015;2015(2):CD001902.
- French JA. Withdrawal of antiepileptic drugs: an individualised approach. Lancet Neurol. 2017;16:493–494.
- Ramos-Lizana J, Aguirre-Rodríguez J, Aguilera-López P, et al. Recurrence risk after withdrawal of antiepileptic drugs in children with epilepsy: a prospective study. Eur J Paediatr Neurol. 2010;14:116–124.
- Britton JW. Antiepileptic drug withdrawal: literature review. Mayo Clin Proc. 2002;77:1378–1388.
- Schachter SC. Determining when to stop antiepileptic drug treatment. Curr Opin Neurol. 2018;31:211–215.
- Stagi S, Lasorella S, Piccorossi A, et al. Cessation of epilepsy therapy in children. Expert Rev Neurother. 2016;16:549–559.
- Lee IC, Li SY, Chen YJ. Seizure recurrence in children after stopping antiepileptic medication: 5-year follow-up. Pediatr Neonatol. 2017;58:338–343.
- Verrotti A, D’Egidio C, Agostinelli S, et al. Antiepileptic drug withdrawal in childhood epilepsy: what are the risk factors associated with seizure relapse? Eur J Paediatr Neurol. 2012;16:599–604.
- Tang L, Xiao Z. Can electroencephalograms provide guidance for the withdrawal of antiepileptic drugs: A meta-analysis. Clin Neurophysiol. 2017;128:297–302.
- Yao J, Wang H, Xiao Z. Correlation between EEG during AED withdrawal and epilepsy recurrence: a meta-analysis. Neurol Sci. 2019;40:1637–1644.
- Shinnar S, Berg AT. Does antiepileptic drug therapy alter the prognosis of childhood seizures and prevent the development of chronic epilepsy? Semin Pediatr Neurol. 1994;1:111–117.
- Hawash KY, Rosman NP. Do partial seizures predict an increased risk of seizure recurrence after antiepilepsy drugs are withdrawn? J Child Neurol. 2003;18:331–337.
- Peters AC, Brouwer OF, Geerts AT, et al. Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy. Neurology. 1998;50:724–730.
- Matricardi M, Brinciotti M, Benedetti P. Outcome after discontinuation of antiepileptic drug therapy in children with epilepsy. Epilepsia. 1989;30:582–589.
- Todt H. The late prognosis of epilepsy in childhood: results of a prospective follow-up study. Epilepsia. 1984;25:137–144.
- Arts WF, Visser LH, Loonen MC, et al. Follow-up of 146 children with epilepsy after withdrawal of antiepileptic therapy. Epilepsia. 1988;29:244–250.
- Dooley J, Gordon K, Camfield P, et al. Discontinuation of anticonvulsant therapy in children free of seizures for 1 year: a prospective study. Neurology. 1996;46:969–974.
- Karalok ZS, Guven A, Öztürk Z, et al. Risk factors for recurrence after drug withdrawal in childhood epilepsy. Brain Dev. 2020;42:35–40.
- Sillanpää M, Schmidt D. Prognosis of seizure recurrence after stopping antiepileptic drugs in seizure-free patients: A long-term population-based study of childhood-onset epilepsy. Epilepsy Behav. 2006;8:713–719.
- Tang X, Yu P, Ding D, et al. Risk factors for seizure reoccurrence after withdrawal from antiepileptic drugs in individuals who have been seizure-free for over 2 years. PLoS One. 2017;12:e0181710.
- Lossius MI, Hessen E, Mowinckel P, et al. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study). Epilepsia. 2008;49:455–463.
- Kerkhof M, Koekkoek JAF, Vos MJ, et al. Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study. J Neurooncol. 2019;142(3):463–470.
- Pilotto C, Liu JF, Walker DA, et al. Seizure characteristics and the use of anti-epileptic drugs in children and young people with brain tumours and epileptic seizures: analysis of regional paediatric cancer service population. Seizure. 2018;58:17–21.
- Perucca P, Scheffer IE, Kiley M. The management of epilepsy in children and adults. Med J Aust. 2018;208:226–233.
- Scheffer IE, Berkovic S, Capovilla G, et al. ILAE Classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58:512–521.
- Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58:522–530.
- Lin J, Ding S, Li X, et al. External validation and comparison of two prediction models for seizure recurrence after the withdrawal of antiepileptic drugs in adult patients. Epilepsia. 2020;61:115–124.
- Ayuga Loro F, Gisbert Tijeras E, Brigo F. Rapid versus slow withdrawal of antiepileptic drugs. Cochrane Database Syst Rev. 2020;1(1):CD005003.